产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 95% | 询价 | |||
| 5mg | 95% | 询价 | |||
| 10mg | 95% | 询价 | |||
| 25mg | 95% | 询价 | |||
| 50mg | 95% | 询价 | |||
| 100mg | 95% | 询价 |
CAS No. |
1620458-09-4 |
|---|---|
英文名称 |
(2R,4S,4aS)-11-fluoro-2,4-dimethyl-8-((S)-4-methyl-2-oxooxazolidin-3-yl)-1,2,4,4a-tetrahydro-2'H,6H-spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4',6'(1'H,3'H)-trione |
别名 |
Angiontensin(1-7);AZD0914;(2R,4S,4aS)-11-Fluoro-1,2,4,4a-tetrahydro-2,4-dimethyl-8-[(4S)-4-methyl-2-oxo-3-oxazolidinyl]spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5(6H),5'(2'H)-pyrimidine]-2',4',6'(1'H,3'H)-trione;ETX0914;AZD0914;Zoliflodacin(AZD0914);CAS#1620458-09-4.;ETX 0914;ETX0914 |
标准英文名 |
(2R,4S,4aS)-11-fluoro-2,4-dimethyl-8-((S)-4-methyl-2-oxooxazolidin-3-yl)-1,2,4,4a-tetrahydro-2'H,6H-spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4',6'(1'H,3'H)-trione |
分子式 |
C22H22FN5O7 |
分子量 |
487.44 |
精确分子量 |
487.15 |
SMILES |
C[C@@H]1CN2C3=C(C=C4C(N5C(=O)OC[C@@H]5C)=NOC4=C3F)CC3(C(=O)NC(=O)NC3=O)[C@H]2[C@H](C)O1 |
标准SMILES |
C[C@H]1COC(=O)N1C1=NOC2=C(F)C3=C(CC4([C@H]5[C@H](C)O[C@H](C)CN35)C(=O)NC(=O)NC4=O)C=C21 |
用途 |
Zoliflodacin (ETX0914; AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor with potent in vitro antibacterial activity against both Gram-positive and Gram-negative organisms, exhibiting an MIC90 value of 0.25 μg/mL against Staphylococcus aureus. |
InChIKey |
ZSWMIFNWDQEXDT-ZESJGQACSA-N |
|
|
评论 |
|---|